Samuel D Colella's Net Worth

$1.19 Billion

Estimate Recalculated Jul 24, 2024 06:46PM EST

Who is Samuel D Colella?

Samuel D Colella has an estimated net worth of $1.19 Billion. This is based on reported shares across multiple companies, which include FLUIDIGM CORP, INSULET CORP, PHASERX, INC., Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, SYMYX TECHNOLOGIES INC, GLAUKOS Corp, VERACYTE, INC., JAZZ PHARMACEUTICALS INC, Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, NOVACEA INC, THERMAGE INC, GENOMIC HEALTH INC, INTRALASE CORP, HELICOS BIOSCIENCES CORP, ARGONAUT TECHNOLOGIES INC, TURNSTONE SYSTEMS INC, DIGITAL IMPACT INC /DE/, and AT ROAD INC.

SEC CIK

Samuel D Colella's CIK is 0001201580

Past Insider Trading and Trends

2014 was Samuel D Colella's most active year for acquiring shares with 81 total transactions. Samuel D Colella's most active month to acquire stocks was the month of October. 2015 was Samuel D Colella's most active year for disposing of shares, totalling 45 transactions. Samuel D Colella's most active month to dispose stocks was the month of October. 2016 saw Samuel D Colella paying a total of $24,276,785.51 for 2,292,491 shares, this is the most they've acquired in one year. In 2003 Samuel D Colella cashed out on 11,552,345 shares for a total of $47,974,748.19, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHASERX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.36%
341.96K
$2.51
$2,997,419.56
1.94M
May 23
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.21%
-414.16K
$23.98
-$816,710.84
2.72M
May 31
Form 4
∞
3.14M
$18.00
-$229,824.00
3.14M
Jun 30
Form 3
—
0
—
—
0
No matching records found

Inogen Inc (INGN) Snapshot price: $7.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-10.90%
-374.67K
$24.30
-$179,534.67
3.06M
Nov 5 - Nov 7
Form 4
-31.05%
-706.33K
—
—
1.57M
Jan 6 - Jan 7
Form 4
—
0
—
—
0
Form 4/A
-16.87%
-464.29K
—
—
2.29M
Dec 18
Form 4
—
0
—
—
0
Form 4
-16.87%
-464.29K
—
—
2.29M
Dec 18
Form 4
-11.64%
-5.34K
$24.89
-$132,961.62
40.57K
Nov 17
Form 4
-21.11%
-728.10K
$25.13
-$237,069.89
2.72M
Nov 12 - Nov 14
Form 4
-19.71%
-2.99K
$24.42
-$73,064.94
12.19K
Nov 10
Form 4
+11.02%
14.47K
$24.30
-$179,534.67
145.72K
Nov 5 - Nov 7
Form 4
-100.00%
-4.65K
$20.76
-$96,455.46
0
Oct 24
Form 4
-100.00%
-1.90K
$20.83
-$39,568.45
0
Oct 9
Form 4
-40.23%
-27.52K
$21.03
-$145,230.72
40.89K
Oct 7 - Oct 8
Form 4
-10.48%
-398.20K
$23.25
-$171,768.04
3.4M
Sep 9
No matching records found

SECOND SIGHT MEDICAL PRODUCTS INC (VANI) Snapshot price: $1.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

NOVACEA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.07M
—
—
2.07M
May 15
Form 3
—
0
—
—
0
No matching records found